APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Growth and Trends Forecast to 2032

Report ID 173976920128 December 2025119 pages

Choose your research edition.

Industry ResearchChemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs include Baxter, Helsinn, Heron Therapeutics, Mundipharma, Sun Pharma, GSK, Haisco, Roche and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Company

Baxter

Helsinn

Heron Therapeutics

Mundipharma

Sun Pharma

GSK

Haisco

Roche

Mylan

Merck

Novartis

Qilu Pharma

Teva

Eisai

Southwest Pharma

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type

5-HT3 Inhibitors

NK1 Inhibitors

Others

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application

Acute CINV

Breakthrough CINV

Delayed CINV

Others

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5-HT3 Inhibitors Table 2. Major Company of NK1 Inhibitors Table 3. Major Company of Others Table 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2027-2032) & (M Units) Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 16. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 18. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 22. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends Table 26. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Drivers Table 27. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Opportunities and Challenges Table 28. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Restraints Table 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2021-2026) & (M Units) Table 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Company (2021-2026) Table 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Company Production Sites and Headquarters Table 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Company, Product Type & Application Table 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2026) & (M Units) Table 42. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2027-2032) & (M Units) Table 47. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 53. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2027-2032) & (M Units) Table 58. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 63. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 65. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 69. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Baxter Company Information Table 73. Baxter Business Overview Table 74. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 76. Baxter Recent Development Table 77. Helsinn Company Information Table 78. Helsinn Business Overview Table 79. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 81. Helsinn Recent Development Table 82. Heron Therapeutics Company Information Table 83. Heron Therapeutics Business Overview Table 84. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 86. Heron Therapeutics Recent Development Table 87. Mundipharma Company Information Table 88. Mundipharma Business Overview Table 89. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 91. Mundipharma Recent Development Table 92. Sun Pharma Company Information Table 93. Sun Pharma Business Overview Table 94. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 96. Sun Pharma Recent Development Table 97. GSK Company Information Table 98. GSK Business Overview Table 99. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 101. GSK Recent Development Table 102. Haisco Company Information Table 103. Haisco Business Overview Table 104. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 106. Haisco Recent Development Table 107. Roche Company Information Table 108. Roche Business Overview Table 109. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 111. Roche Recent Development Table 112. Mylan Company Information Table 113. Mylan Business Overview Table 114. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 116. Mylan Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 121. Merck Recent Development Table 122. Novartis Company Information Table 123. Novartis Business Overview Table 124. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 126. Novartis Recent Development Table 127. Qilu Pharma Company Information Table 128. Qilu Pharma Business Overview Table 129. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 131. Qilu Pharma Recent Development Table 132. Teva Company Information Table 133. Teva Business Overview Table 134. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 136. Teva Recent Development Table 137. Eisai Company Information Table 138. Eisai Business Overview Table 139. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 141. Eisai Recent Development Table 142. Southwest Pharma Company Information Table 143. Southwest Pharma Business Overview Table 144. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 146. Southwest Pharma Recent Development Table 147. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 148. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 149. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2026) Table 150. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032) & (M Units) Table 151. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country (2021-2026) Table 155. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Country (2027-2032) Table 157. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 158. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 159. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2026) Table 160. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032) & (M Units) Table 161. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country (2021-2026) Table 165. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 169. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032) & (M Units) Table 171. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country (2021-2026) Table 175. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Country (2027-2032) Table 177. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 178. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 179. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2026) Table 180. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032) & (M Units) Table 181. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country (2021-2026) Table 185. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 189. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032) & (M Units) Table 191. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country (2021-2026) Table 195. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List Table 200. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Image Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (2021-2032) & (M Units) Figure 5. 5-HT3 Inhibitors Image Figure 6. Global 5-HT3 Inhibitors Sales YoY Growth (2021-2032) & (M Units) Figure 7. NK1 Inhibitors Image Figure 8. Global NK1 Inhibitors Sales YoY Growth (2021-2032) & (M Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Acute CINV Image Figure 26. Global Acute CINV Sales YoY Growth (2021-2032) & (M Units) Figure 27. Breakthrough CINV Image Figure 28. Global Breakthrough CINV Sales YoY Growth (2021-2032) & (M Units) Figure 29. Delayed CINV Image Figure 30. Global Delayed CINV Sales YoY Growth (2021-2032) & (M Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Others
Applications
  • Acute CINV
  • Breakthrough CINV
  • Delayed CINV
  • Others
Companies covered
  • Baxter
  • Helsinn
  • Heron Therapeutics
  • Mundipharma
  • Sun Pharma
  • GSK
  • Haisco
  • Roche
  • Mylan
  • Merck
  • Novartis
  • Qilu Pharma
  • Teva
  • Eisai
  • Southwest Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Type
  6. 1.3.1 5-HT3 Inhibitors
  7. 1.3.2 NK1 Inhibitors
  8. 1.3.3 Others
  9. 1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type
  10. 1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
  2. 2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Drivers
  3. 2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Opportunities and Challenges
  4. 2.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (2021-2026)
  4. 3.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Company, Product Type & Application
  7. 3.7 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Tier 1, Tier 2, and Tier 3
4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Regional Status and Outlook
  1. 4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Size by Region
  3. 4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application
  1. 5.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Application
  2. 5.1.1 Acute CINV
  3. 5.1.2 Breakthrough CINV
  4. 5.1.3 Delayed CINV
  5. 5.1.4 Others
  6. 5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application
  7. 5.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Helsinn
  8. 6.2.1 Helsinn Company Information
  9. 6.2.2 Helsinn Business Overview
  10. 6.2.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  12. 6.2.5 Helsinn Recent Developments
  13. 6.3 Heron Therapeutics
  14. 6.3.1 Heron Therapeutics Company Information
  15. 6.3.2 Heron Therapeutics Business Overview
  16. 6.3.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  18. 6.3.5 Heron Therapeutics Recent Developments
  19. 6.4 Mundipharma
  20. 6.4.1 Mundipharma Company Information
  21. 6.4.2 Mundipharma Business Overview
  22. 6.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  24. 6.4.5 Mundipharma Recent Developments
  25. 6.5 Sun Pharma
  26. 6.5.1 Sun Pharma Company Information
  27. 6.5.2 Sun Pharma Business Overview
  28. 6.5.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  30. 6.5.5 Sun Pharma Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Haisco
  38. 6.7.1 Haisco Company Information
  39. 6.7.2 Haisco Business Overview
  40. 6.7.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  42. 6.7.5 Haisco Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  66. 6.11.5 Novartis Recent Developments
  67. 6.12 Qilu Pharma
  68. 6.12.1 Qilu Pharma Company Information
  69. 6.12.2 Qilu Pharma Business Overview
  70. 6.12.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  72. 6.12.5 Qilu Pharma Recent Developments
  73. 6.13 Teva
  74. 6.13.1 Teva Company Information
  75. 6.13.2 Teva Business Overview
  76. 6.13.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  78. 6.13.5 Teva Recent Developments
  79. 6.14 Eisai
  80. 6.14.1 Eisai Company Information
  81. 6.14.2 Eisai Business Overview
  82. 6.14.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  84. 6.14.5 Eisai Recent Developments
  85. 6.15 Southwest Pharma
  86. 6.15.1 Southwest Pharma Company Information
  87. 6.15.2 Southwest Pharma Business Overview
  88. 6.15.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  90. 6.15.5 Southwest Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
  2. 7.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
  6. 7.2.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
  2. 8.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
  6. 8.2.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
  2. 10.1.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
  6. 10.2.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain Analysis
  2. 12.1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process
  7. 12.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors
  10. 12.2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst